Enrichment in factors such as CD2, CD28, GZMB, and INFG also suggests the disrupted signaling in XPO1-E571K CLL cells may influence surrounding immune cells, contributing to the immune dysfunction attributed to CLL patients. Here, XPO1 is linked to B-cell chronic lymphocytic leukemia.